Latigo Biotherapeutics, Inc. Common Stock（LTGO）價格預測LTGOLatigo Biotherapeutics, Inc. Common Stock

Alphio's LTGO stock price prediction model matches the current Latigo Biotherapeutics, Inc. Common Stock tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $13.85 (-0.73%). The 1-week path is $14.16 (+1.47%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

Latigo Biotherapeutics appears to be a good buy right now, with a current price of $15.02 and a strong analyst price target of $50, suggesting a potential upside of 233%. Additionally, the company's lead asset, LTG-001, is expected to show promising results in upcoming studies, which could drive further price appreciation. However, the main risk is its negative earnings per share of -0.41, indicating ongoing financial losses that investors should monitor closely.

Latigo Biotherapeutics, Inc. Common Stock (LTGO) last closed at $13.9499998, losing -10.23%. These facts feed the 1-day and 1-week LTGO price prediction above.